『Gynecologic Oncology Update』のカバーアート

Gynecologic Oncology Update

Gynecologic Oncology Update

著者： Dr. Neil Love
無料で聴く

This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.Copyright 2025 Research To Practice. All Rights Reserved 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4

    Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4
    2026/10/23

    Featuring perspectives from Prof Susana Banerjee, including the following topics:

    • Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response, asymptomatic creatine phosphokinase elevation and mild facial rash — Dr Stover (0:00)
    • Case: A woman in her early 30s with recurrent metastatic low-grade serous ovarian cancer, originally offered hospice due to poor condition, who receives avutometinib/defactinib with an excellent response — Dr Hussein (7:58)
    • Case: A woman in her late 30s with multiregimen-recurrent folate receptor alpha-positive low-grade serous ovarian cancer (HER2 IHC 2+) who receives mirvetuximab soravtansine — Dr Cobb (18:21)

    CME information and select publications
    続きを読む 一部表示
    28 分
  • Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

    Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3
    2026/10/22

    Featuring perspectives from Prof Susana Banerjee, including the following topics:

    • Overview of the biology and treatment of low-grade serous ovarian cancer (0:00)
    • Mechanism of action of avutometinib/defactinib (10:16)
    • RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian cancer (14:32)
    • Ongoing clinical trials in low-grade serous ovarian cancer (27:57)

    CME information and select publications
    続きを読む 一部表示
    32 分
  • Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

    Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
    2026/10/14

    Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

    • Case: A woman in her mid 50s with BRCA1-mutated recurrent ovarian cancer receives mirvetuximab soravtansine — Ursula Matulonis, MD (0:00)

    CME information and select publications
    続きを読む 一部表示
    12 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません